Candel Therapeutics advances Phase 2b trial for innovative prostate cancer treatment

(4:24)

Candel Therapeutics progresses Phase 3 trial for treatment in high-risk localized prostate cancer

(4:19)

Paul Peter Tak, CEO of Candel Therapeutics, Discusses the Treatment of Glioblastoma

(4:10)

Martin Shkreli Reacts To Candel Therapeutics Positive Phase 3 Trail

(9:37)

Candel Therapeutics stock up 172% after Phase III prostate cancer success

(3:59)

DON'T BUY Candel Therapeutics Stock (Until You Watch This Analysis) #CADL

(2:58)

Candel Therapeutics Poised for Breakthrough in Cancer Therapies, Key Trials to Read Out by Year-End

(6:50)

Cadrenal Therapeutics Fireside Chat @ Lytham Partners 2025 Investor Healthcare Summit

(20:41)

Reiki to Clear Candles 💮

(10:9)

SNAP-CAR: Immune Cell-Based Therapy for Oncology and Autoimmune Diseases

(3:15)

Builders #22 w/ Nabiha Saklayen - Co-Founder \u0026 CEO @ Cellino | BIOS

(51:52)

\

(1:33:36)

Ear Candle Wax Removal Experiment | See INSIDE the Ear Canal while Ear Candling! 😮

(10:41)

Cramer: This biotech stock could be worth over $100 billion on an FDA approval

(5:19)

Turing CEO Martin Shkreli Talks 5,000% Drug Price Hike (Full Interview) | CNBC

(6:17)

THE L-CARNITINE SEMINAR (Replacing the eBook)

(1:22)

Mastering the Art of Radioligand therapy

(59:56)

CADL Stock (Candel Therapeutics stock) CADL STOCK PREDICTION CADL STOCK analysis CADL stock news

(1:11)

Candel Therapeutics Stock Gaining Bullish Momentum In 2025

(2:16)

Candel Therapeutics Sees Dramatic Surge in Short Interest Amid Insider Trading Activity

(6:30)

Builders #21 w/ Paul Peter Tak - President \u0026 CEO @ Candel Therapeutics | BIOS

(1:17:34)

Candel Therapeutics (NASDAQ: $CADL): Revolutionizing Glioma Treatment and Redefining Hope

(8:32)

Targeting Solid Tumors with Oncolytic Viruses

(38:13)

The BioHub - The Avetix Podcast - Episode 5 - Paul Peter Tak

(32:40)

Candel Therapeutics presents preclinical data with CAN-3110 in Melanoma model at SITC annual Meeting

(6:35)

On Insider Selling, Bitcoin | Hims, Bumble, Urogen, Candel, Reviva Stock Review | Martin Shkreli

(21:14)

Candel Therapeutics (NASDAQ: $CADL) Reports Positive Data From Phase 2 Trial Of CAN-2409

(11:6)

CASE STUDY. MoA animations about virus-based immunotherapy platforms for Candel Therapeutics (NA...

(38)

ON THE VERGE OF BREAKOUT : CADL STOCK ANALYSIS | CANDEL THERAPEUTICS INC STOCK

(2:4)

$CADL enLIGHTEN Discovery Platform Aims To Tackle Complexities Of Tumor Microenvironments

(11:8)